In today’s COVID-19 environment, more than ever, the myMatrixx team understands how to innovate and adapt to the changing workforce conditions. Our mission, to provide you with the highest level of customized service, has never been more important. We care deeply about our partners and their injured workers, and we are committed to providing you with the comprehensive information and resources you need to make decisions to support and grow your business.
Please use this resource to stay informed on how myMatrixx is addressing COVID-19 and check in often, as this page is updated frequently.
Image
COVID-19 Helpful Resources
Learn what the Coronavirus is, how it started, symptoms, prevention, and more:
COVID-19 Position Paper
myMatrixx View on COVID-19 Vaccination and Workers' Compensation Coverage
Addressing the Unique Behavioral Care Needs of Post-COVID-19 Cases
June 01, 2022
Two years on, the COVID-19 pandemic continues to impact society, including our injured workforce. While patients with compensable work-related COVID-19 claims face many of the same obstacles as the broader patient population, stakeholders in the industry should be aware of several unique considerations.
Learn more
New myMatrixx COVID-19 Supplement on Emerging Oral Antiviral Medications
March 28, 2022
Download our new COVID-19 supplement the myMatrixx clinical team developed that provides an overview of molnupiravir and Paxlovid (nirmatrelvir and ritonavir), and their potential impact on workers’ compensation pharmacy.
Learn more
Ten Surprising Stats About Drug Overdoses
September 01, 2021
In observing International Overdose Awareness Day (August 31), myMatrixx parent company, Cigna, gathered several facts related to drug overdoses that affects everyone worldwide.
Learn more
FDA Approval for First COVID-19 Vaccine
August 23, 2021
The U.S. Food and Drug Administration (FDA) fully approved the first vaccine for active prevention of COVID-19 in individuals 16 years of age and older.
Learn more
Cigna Updates COVID-19 Vaccination and Testing Policy
August 18, 2021
myMatrixx parent company Cigna has established new requirements to help protect its workforce.
Learn more
COVID-19 Booster Authorized for Immunocompromised Individuals
August 12, 2021
On August 12, 2021, the FDA updated the Emergency Use Authorization (EUA) for the COVID-19 vaccines from Moderna and Pfizer/BioNTech.
Learn more
Monitoring Post-COVID Syndrome from a Workers’ Comp Perspective
July 14, 2021
One result of the pandemic that surprised many in our field last year was the limited impact of COVID-19 treatment on retail pharmacy spend.
Learn more
Phil Walls Joins Industry Analyst John Ruser for On-Demand Webinar on Drug Trends
June 24, 2021
myMatrixx Chief Clinical Officer Phil Walls joined John Ruser, PhD, President and CEO of the Workers’ Compensation Research Institute for an on-demand webinar available starting June 24, on the Risk & Insurance website.
Learn more